Cargando…
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633864/ https://www.ncbi.nlm.nih.gov/pubmed/36349202 http://dx.doi.org/10.1002/cti2.1429 |
| _version_ | 1784824335032123392 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9633864 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96338642022-11-07 Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma Clin Transl Immunology Corrigendum John Wiley and Sons Inc. 2022-11-03 /pmc/articles/PMC9633864/ /pubmed/36349202 http://dx.doi.org/10.1002/cti2.1429 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title | Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title_full | Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title_fullStr | Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title_full_unstemmed | Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title_short | Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma |
| title_sort | memory stem t cells modified with a redesigned cd30‐chimeric antigen receptor show an enhanced antitumor effect in hodgkin lymphoma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633864/ https://www.ncbi.nlm.nih.gov/pubmed/36349202 http://dx.doi.org/10.1002/cti2.1429 |